Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

16.14
Delayed Data
As of Feb 05
 -0.66 / -3.93%
Today’s Change
13.27
Today|||52-Week Range
33.74
-10.98%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close16.80
Today’s open16.74
Day’s range16.10 - 16.82
Volume2,226,728
Average volume (3 months)1,921,260
Market cap$976.2M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)+203.85%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+190.87%
P/E ratio21.1
Price/Sales2.74
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
DNAIProNAi Therapeutics ...-0.56-7.21%
OASMOasmia Pharmaceutica...0.000.00%
NEPTNeptune Technologies...-0.05-4.39%
VBLTVascular Biogenics L...+0.23+7.28%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 3, 2016
EPS forecast (this quarter)$0.29
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

Partner Offers